LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Disrupted Genetic Systems Discovered in Autistic Brain

By LabMedica International staff writers
Posted on 17 May 2012
Print article
By investigating gene collections rather than individual genes, researchers have now identified specific functional systems with genetic disruptions in the autistic brain.

Autism, the severe state resulting from multiple neurodevelopmental disorders named autism spectrum disorders (ASDs), is known to have a strong genetic basis. However, efforts to identify the responsible genes have so far had mixed results due to the influence of many different genes as well as that different genes are involved in different autistic individuals. Scientists at the Hebrew University of Jerusalem (HUJ; Jerusalem, Israel) chose to examine groups of genes to identify and better understand multiple pathways involved in ASDs.

The study, published in the journal PLoS Genetics in March 2012, showed that the different genes involved in autism tend to be involved in specific brain processes. This can explain similarities in the behavioral symptoms of different autistics as well as the large spectrum of behaviors observed in different autistic individuals.

The main goal of the project, conducted by Dr. Sagiv Shifman and his doctoral student Eyal Ben-David at the HUJ Department of Genetics, was to test the contribution of rare genetic mutations as well as genetic variations common in the population, and to see whether these different types of genetic risk factors are related. To that end, the scientists used the Allen Brain Atlas RNA microarray dataset to construct a robust network of the human brain transcriptome based on the expression pattern of genes across different brain areas. This allowed them to discover groups of genes with shared function in the brain. Next, based on genetic data from thousands of families with autistic children, the researchers studied the contribution of different groups of genes to autism.

To their surprise, they found -- when looking at mutations found in autism as well as thousands of common gene variants that are more frequently seen in autistics -- that these mutations and variations are located in specific functional groups, that the genetic risk factors were enriched in specific groups of connected genes. When looking at families with one autistic individual (sporadic cases), and in families where there is more than one affected individual (multiplex cases), the same variants were seen acting in both cases. These groups of genes are highly active in the first year of life, and the strongest enriched of risk factors corresponded to a group of genes involved in processes of learning, memory, and sensory perception.

Shifman and Ben-David believe their work could help pave the way for development of genetic scans for early diagnosis of autism, and, by concentrating on specific gene groups, for the design of effective therapeutic drugs that could alleviate symptoms in autistics with different genetic backgrounds.

Related Links:

Hebrew University of Jerusalem


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Piezoelectric Micropump
Disc Pump
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.